{
    "2019-09-10": [
        [
            {
                "time": "2019-09-10",
                "original_text": "The Zacks Analyst Blog Highlights: Allergan, Merck, Roche, J&J and Bristol-Myers",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst Blog",
                        "Allergan",
                        "Merck",
                        "Roche",
                        "J&J",
                        "Bristol-Myers"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-10",
                "original_text": "Theravance Announces Positive Early Data on JAK Inhibitor",
                "features": {
                    "keywords": [
                        "Theravance",
                        "Positive",
                        "Early Data",
                        "JAK Inhibitor"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-09-10",
                "original_text": "10 Healthcare Stocks to Buy Despite the Headlines",
                "features": {
                    "keywords": [
                        "Healthcare Stocks",
                        "Buy",
                        "Headlines"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-10",
                "original_text": "Health Care Sector Update for 09/10/2019: CANF, MNK, MESO, JNJ, PFE, MRK, ABT, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "Update",
                        "CANF",
                        "MNK",
                        "MESO",
                        "JNJ",
                        "PFE",
                        "MRK",
                        "ABT",
                        "AMGN"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-09-10",
                "original_text": "What To Make of Roche's Drugs With $21 Billion In Sales Nearing Patent Expiry?",
                "features": {
                    "keywords": [
                        "Roche",
                        "Drugs",
                        "Sales",
                        "Patent Expiry"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-09-10",
                "original_text": "Bristol-Myers Squibb's Revenues: How Does Bristol-Myers Squibb Make Money?",
                "features": {
                    "keywords": [
                        "Bristol-Myers Squibb",
                        "Revenues",
                        "Make Money"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}